SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
Arcutis Biotherapeutics, Inc.
@ARQT_InsiderForm 4 Filing: Welgus Howard G. Sells $148,755.613 of $ARQT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Arcutis Biotherapeutics, Inc.
Ticker: $ARQT
Transaction Value
$148,755.613
Price/Share: $16.85
transaction date
2026-06-15
Shares: 8,827
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Welgus Howard G., holds the title of Director at Arcutis Biotherapeutics, Inc..
On 2026-06-15, the insider transacted 8,827 shares.The shares were transacted at a weighted average price of $16.85 per share, resulting in a total market-relevant value of $148,755.613.
Executive Summary Summary
Welgus Howard G. (Director) sold $149K of $ARQT
Post-Transaction Position: 38,378 shares
SEC Accession No: 0001628280-26-044079 (CIK: 1801050)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.